A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
Clinical trial NCT05947344 · RECRUITING
Trial details
- NCT number
- NCT05947344
- Sponsor
- Zhejiang ACEA Pharmaceutical Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-08
- Primary completion
- 2025-12-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.